EPOLADERM Trademark

Trademark Overview

On Thursday, November 14, 2019, a trademark application was filed for EPOLADERM with the United States Patent and Trademark Office. The USPTO has given the EPOLADERM trademark a serial number of 88692677. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, June 26, 2023. This trademark is owned by Virpax Pharmaceuticals Inc.. The EPOLADERM trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for human use containing diclofenac for the local treatment of the painful and inflammatory states of a rheumatic or traumatic nature
epoladerm

General Information

Serial Number88692677
Word MarkEPOLADERM
Filing DateThursday, November 14, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, June 26, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 31, 2020

Trademark Statements

Goods and ServicesPharmaceutical preparations for human use containing diclofenac for the local treatment of the painful and inflammatory states of a rheumatic or traumatic nature

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, November 20, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameVirpax Pharmaceuticals Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressMalvern, PA 18015
Party NameVirpax Pharmaceuticals Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMalvern, PA 18015

Trademark Events

Event DateEvent Description
Monday, June 26, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, June 26, 2023ABANDONMENT - NO USE STATEMENT FILED
Wednesday, December 7, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 6, 2022SOU EXTENSION 5 GRANTED
Monday, November 28, 2022SOU EXTENSION 5 FILED
Friday, December 2, 2022NOTICE OF REVIVAL - E-MAILED
Friday, December 2, 2022EXTENSION RECEIVED WITH TEAS PETITION
Friday, December 2, 2022PETITION TO REVIVE-GRANTED
Friday, December 2, 2022TEAS PETITION TO REVIVE RECEIVED
Friday, May 27, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, May 25, 2022SOU EXTENSION 4 GRANTED
Wednesday, May 25, 2022SOU EXTENSION 4 FILED
Wednesday, May 25, 2022TEAS EXTENSION RECEIVED
Wednesday, December 8, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 7, 2021SOU EXTENSION 3 GRANTED
Friday, November 26, 2021SOU EXTENSION 3 FILED
Friday, December 3, 2021NOTICE OF REVIVAL - E-MAILED
Friday, December 3, 2021EXTENSION RECEIVED WITH TEAS PETITION
Friday, December 3, 2021PETITION TO REVIVE-GRANTED
Friday, December 3, 2021TEAS PETITION TO REVIVE RECEIVED
Wednesday, May 26, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, May 24, 2021SOU EXTENSION 2 GRANTED
Monday, May 24, 2021SOU EXTENSION 2 FILED
Monday, May 24, 2021TEAS EXTENSION RECEIVED
Friday, March 5, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, March 4, 2021SOU EXTENSION 1 GRANTED
Friday, November 27, 2020SOU EXTENSION 1 FILED
Monday, March 1, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, December 3, 2020NOTICE OF REVIVAL - E-MAILED
Thursday, December 3, 2020EXTENSION RECEIVED WITH TEAS PETITION
Thursday, December 3, 2020PETITION TO REVIVE-GRANTED
Thursday, December 3, 2020TEAS PETITION TO REVIVE RECEIVED
Tuesday, May 26, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 31, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 31, 2020PUBLISHED FOR OPPOSITION
Wednesday, March 11, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, February 21, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 19, 2020ASSIGNED TO EXAMINER
Wednesday, November 20, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, November 18, 2019NEW APPLICATION ENTERED

Related Keywords

epoladerm states inflammatory rheumatic traumatic nature painful treatment human preparations containing